Can Benalyn (dextromethorphan) cause gross hematuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Benalyn (Dextromethorphan) Cause Gross Hematuria?

No, dextromethorphan (Benalyn) is not a recognized cause of gross hematuria in standard clinical practice, though there is one isolated case report of hematuria following massive recreational overdose combined with guaifenesin.

Evidence Assessment

The FDA drug label for Benalyn 1 does not list hematuria as a known adverse effect. The medication is indicated for topical use only and contains no warnings about urinary tract effects.

Case Report of Hematuria with Dextromethorphan

One case report 2 describes a 22-year-old male who developed severe bilateral flank pain, hematuria, and oliguria after recreational ingestion of guaifenesin and dextromethorphan. The patient had bilateral ureteral obstruction and acute renal failure, suspected to be secondary to precipitation of medication metabolites in the urine. This represents drug abuse at supratherapeutic doses, not therapeutic use.

Medications Actually Associated with Hematuria

A comprehensive pharmacovigilance analysis 3 of 15,687 FDA reports and 15,007 EudraVigilance reports identified the medications most frequently associated with hematuria:

  • Anticoagulants: Rivaroxaban, warfarin, dabigatran, apixaban, enoxaparin
  • Antiplatelet agents: Aspirin, clopidogrel
  • Other: Cyclophosphamide, lansoprazole, ibuprofen

Dextromethorphan was not identified among medications commonly associated with hematuria in this large-scale analysis.

Clinical Context

When evaluating gross hematuria 4, 5:

  • Any episode of gross hematuria warrants urologic evaluation, with cancer risk >10% in most series and >25% in some
  • Focus your history on actual risk factors: age, smoking history (pack-years), anticoagulant/antiplatelet use, occupational exposures
  • The 2025 AUA/SUFU guidelines 5 provide risk stratification based on degree of hematuria, age, and smoking history—not on cough suppressant use

Bottom Line

If a patient on dextromethorphan develops gross hematuria, investigate the standard differential diagnosis rather than attributing it to the medication. Pursue the evaluation as you would for any patient with gross hematuria 4, including urologic referral for cystoscopy and imaging, even if self-limited. The hematuria is almost certainly unrelated to therapeutic dextromethorphan use.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.